Clinical Trial Update: A Pharmacokinetic/Pharmacodynamic Study of Eurartesim Dispersible Formulation in Infants With P.Falciparum Malaria [Phase 2]

View source ↗

Summary

Completed Phase 2 pharmacokinetic/pharmacodynamic study of Eurartesim dispersible formulation in infants with Plasmodium falciparum malaria.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plasmodium Falciparum Malaria

Drugs mentioned

• Eurartesim (piperaquine tetraphosphate; artenimol)

Snippet

Sponsor: sigma-tau i.f.r. S.p.A. | Conditions: Malaria,Falciparum | Phase 2 | Status: COMPLETED